Abstract |
The use of intraarticular triamcinolone hexacetonide in the management of persistent arthritis of the knee joint that is unresponsive to nonsteroidal anti-inflammatory drugs was prospectively evaluated in 40 children with chronic arthritis. Of 49 knees that were injected, 63.3% maintained complete resolution of effusion and other signs of inflammation at the 6-month followup. This favorable outcome correlated with a young age, a short disease duration, and a higher dose of triamcinolone hexacetonide. At the 12-month followup, 45% of the injected knees remained in remission.
|
Authors | R C Allen, K R Gross, R M Laxer, P N Malleson, R D Beauchamp, R E Petty |
Journal | Arthritis and rheumatism
(Arthritis Rheum)
Vol. 29
Issue 8
Pg. 997-1001
(Aug 1986)
ISSN: 0004-3591 [Print] United States |
PMID | 3741522
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Triamcinolone Acetonide
- triamcinolone hexacetonide
|
Topics |
- Arthritis, Juvenile
(drug therapy)
- Child
- Child, Preschool
- Female
- Humans
- Injections, Intra-Articular
- Knee Joint
- Male
- Triamcinolone Acetonide
(administration & dosage, analogs & derivatives, therapeutic use)
|